By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Male boldness causes COVID-19 death, go figure. This ridiculous quackery from Brazil is based on fudged clinical trials, sponsored by an obscure Californian hair loss business, and even Torello Lotti is on board!
“A consumable component, magnetic beads, used by the laboratory was supplied by Magnacell Ltd, a company that has Dr T Jurkowski as a director. Cardiff University did not tender for these consumables at the time”.
Israeli scientists discovered a cure for coronavirus! Their proprietary PLX cells from placenta deliver 100% survival rate both against COVID-19 and a nuclear holocaust. The stocks soar.
Euroimmun founder Winfried Stöcker replies to criticism of his company’s publications: “Dr. Elisabeth Bik’s observations are not suitable to bring us into disrepute.”
EuroImmun is a German diagnostics biotech, founded by the most charming Professor Stöcker and recently sold to PerkinElmer. Elisabeth Bik checked some of company’s papers, many coauthored by Stöcker himself, and she raised questions. The company says this “testifies to a lack of knowledge of the matter”.
In 2018, the pharma giant Sanofi appointed with John Reed a new R&D head. Apparently Sanofi does not believe in PubPeer.
Patricia Murray uncovers the business secrets of the Nobelist Martin Evans and his partner Ajan Reginald. It seems the magic iMP cells used to treat patients in Greece were drawn from the blood of patients in Swansea, for the purpose of a secret PhD thesis. There is no serious science behind it, only serious investor money and a fraudulent patent.
German diabetologist Kathrin Maedler is a central figure of a questionable academic dynasty. Using Photoshop simulations, she discovered a cure for diabetes, which was then allegedly validated in clinical trials led by her Swiss PhD advisor Marc Donath. 15 years later, the Maedler-Donath diabetes cure was proven as utterly ineffective by same Donath, in another clinical trial. Maedler’s own PhD student, Amin Ardestani is group leader in Bremen, despite data irregularities and unacknowledged textual reuse in his thesis.
This is a new episode of the data manipulation affair around Weizmann Institute of Science in Rehovot, Israel (and another guestContinue Reading
Five months ago, I reported about data integrity concerns in 6 publications authored by Min-Jean Yin, who had been workingContinue Reading
For Better Science